Kurs
+4,25%
Kurs
+4,25%
Open
75,30
High
78,50
Low
75,00
Close
78,50
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
39,2 MNOK
Likviditet
39,2 MNOK
Rel. mcap
4,35%
Antal aktier
508 228
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2026-02-25 | N/A | Bokslutskommuniké 2025 |
| 2025-11-26 | N/A | Kvartalsrapport 2025-Q3 |
| 2025-08-20 | N/A | Kvartalsrapport 2025-Q2 |
| 2025-05-22 | N/A | Årsstämma |
| 2025-05-14 | N/A | Kvartalsrapport 2025-Q1 |
| 2025-02-26 | N/A | Bokslutskommuniké 2024 |
| 2024-11-27 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-21 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2024-05-16 | - | Årsstämma |
| 2024-05-14 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-11-15 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-23 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-16 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-12 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2023-05-11 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-11-23 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-24 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-16 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-13 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2022-05-12 | - | Årsstämma |
| 2022-03-31 | - | Bokslutskommuniké 2021 |
| 2021-12-22 | - | Extra Bolagsstämma 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-06 | - | X-dag ordinarie utdelning NYKD 0.00 NOK |
| 2021-05-05 | - | Årsstämma |
| 2021-04-21 | - | Bokslutskommuniké 2020 |
| 2020-11-17 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-07 | - | Split NYKD 1:5 |
| 2020-07-06 | - | Extra Bolagsstämma |
| 2020-05-12 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | Extra Bolagsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2021-04-22 18:28:25
Primary insider Christian Åbyholm, a member of the VACCIBODY AS board,
represents Andenaesgruppen (including Kvantia AS and Christiania Skibs AS). As
part of a process to streamline the ownership structure of Andenaesgruppen,
Kvantia AS has today sold 700,000 Vaccibody shares to Finyield AS at NOK 74 per
share. Finyield AS is one of the owners of Kvantia AS. After the transaction
Christian Åbyholm (board member) through Caaby AS holds 1,995,895 Vaccibody
shares and 100,000 warrants and Andenaesgruppen (through Kvantia AS and
Christiania Skibs AS) represented by Christian Åbyholm owns 17,170,575 Vaccibody
shares and in addition Norda ASA represented by Christian Åbyholm owns 7,996,755
Vaccibody shares.